Authors: Cosentini, E Haberl, I Pertschy, P Teleky, B Mallinger, R Baumgartner, G Wenzl, E Hamilton, G

Citation: E. Cosentini et al., The differentiation inducers phenylacetate and phenylbutyrate modulate camptothecin sensitivity in colon carcinoma cells in vitro by intracellular acidification, INT J ONCOL, 19(5), 2001, pp. 1069-1074

Authors: Hejna, M Hamilton, G Brodowicz, T Haberl, I Fiebiger, WCC Scheithauer, W Virgolini, I Kostler, WJ Oberhuber, G Raderer, M

Citation: M. Hejna et al., Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract, ANTICANC R, 21(2A), 2001, pp. 1183-1187

Authors: Theyer, G Durer, A Theyer, U Haberl, I Ulsperger, E Baumgartner, G Hamilton, G

Citation: G. Theyer et al., Measurements of free and total PSA, tissue polypeptide-specific antigen (TPS), and CYFRA 21-1 in prostate cancer patients under intermittent androgensuppression therapy, PROSTATE, 41(2), 1999, pp. 71-77

Authors: Hejna, M Haberl, I Raderer, M

Citation: M. Hejna et al., Nonsurgical management of malignant thymoma, CANCER, 85(9), 1999, pp. 1871-1884

Authors: Raderer, M Hamilton, G Kurtaran, A Valencak, J Haberl, I Hoffmann, O Kornek, GV Vorbeck, F Hejna, MHL Virgolini, I Scheithauer, W

Citation: M. Raderer et al., Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results, BR J CANC, 79(3-4), 1999, pp. 535-537